As of 28 October 2025, the Health Technology Assessment Council has completed the evidence appraisal on the assessment of moderate complexity nucleic acid amplification tests (NAATs) for the diagnosis multi-drug resistant tuberculosis (MDR-TB) with simultaneous isoniazid (INH) and rifampicin (Rif) resistance testing for possible government financing. The HTA Council hereby releases its preliminary recommendation on continue reading : HTA Council Preliminary Recommendation on Moderate Complexity Nucleic Acid Amplification Tests (NAAT) for the Diagnosis of Multi-drug Resistant Tuberculosis (MDR-TB) with Simultaneous Isoniazid and Rifampicin Resistance Testing
HTA Council Preliminary Recommendation on Biannual Ultrasound (US) Combined with Alpha Fetoprotein (AFP) Test for the Screening of Adults at High Risk to Develop Hepatocellular Carcinoma (HCC)
As of 28 October 2025, the Health Technology Assessment (HTA) Council has completed the evidence appraisal on the assessment of Biannual Ultrasound (US) combined with Alpha Fetoprotein (AFP) test as screening test for adults at high risk to develop hepatocellular carcinoma (HCC) for possible government financing. The HTA Council hereby releases its preliminary recommendation on continue reading : HTA Council Preliminary Recommendation on Biannual Ultrasound (US) Combined with Alpha Fetoprotein (AFP) Test for the Screening of Adults at High Risk to Develop Hepatocellular Carcinoma (HCC)
HTA Council Preliminary Recommendation on Rotavirus Vaccine (Live, Attenuated) Monovalent G1P[8] Stain Porcine Circovirus (PCV)- Free for the prevention of Gastroenteritis caused by Rotavirus Infection in Children one (1) year of age
Update as of 11 November 2025 : Since the public consultation and appeals period for the HTA Council Preliminary Recommendation on Rotavirus Vaccine (live, attenuated) monovalent G1P[8] strain porcine circovirus (PCV) – free ended on 04 November 2025 without any appeals received, this preliminary HTA Council recommendation lapsed into the Final Recommendation and was transmitted on 11 November 2025 to the Secretary of continue reading : HTA Council Preliminary Recommendation on Rotavirus Vaccine (Live, Attenuated) Monovalent G1P[8] Stain Porcine Circovirus (PCV)- Free for the prevention of Gastroenteritis caused by Rotavirus Infection in Children one (1) year of age
HTA Council Preliminary Recommendation Pneumococcal Conjugate Vaccines (PCV) for elderly adults 60 years old and above
As of 19 September 2025, the Health Technology Assessment (HTA) Council has completed the evidence appraisal on the assessment of pneumococcal vaccines for the prevention of disease caused by Streptococcus pneumoniae in elderly adults 60 years old and above, including the following vaccine regimen: (1) pneumococcal conjugate vaccine 13 (PCV13) in sequence to pneumococcal polysaccharide continue reading : HTA Council Preliminary Recommendation Pneumococcal Conjugate Vaccines (PCV) for elderly adults 60 years old and above
HTA Council Preliminary Recommendation Pneumococcal Conjugate Vaccines (PCV) for elderly adults 60 years old and above
As of 19 September 2025, the Health Technology Assessment (HTA) Council has completed the evidence appraisal on the assessment of pneumococcal vaccines for the prevention of disease caused by Streptococcus pneumoniae in elderly adults 60 years old and above, including the following vaccine regimen: (1) pneumococcal conjugate vaccine 13 (PCV13) in sequence to pneumococcal polysaccharide continue reading : HTA Council Preliminary Recommendation Pneumococcal Conjugate Vaccines (PCV) for elderly adults 60 years old and above